A. Iyevleva

发表

Double heterozygotes among breast cancer patients analyzed for BRCA1, CHEK2, ATM, NBN/NBS1, and BLM germ-line mutations

T. Dörk, N. Bogdanova, A. Jakubowska, 2014, Breast Cancer Research and Treatment.

Non-founder BRCA1 mutations in Russian breast cancer patients.

P. Devilee, A. Sokolenko, E. Imyanitov, 2010, Cancer letters.

PCR-based analysis of PD-L1 RNA expression in lung cancer: comparison with commonly used immunohistochemical assays

E. Imyanitov, E. Preobrazhenskaya, A. Iyevleva, 2022, Annals of Diagnostic Pathology.

Survival Outcomes in EGFR Mutation-Positive Lung Cancer Patients Treated with Gefitinib until or beyond Progression

E. Imyanitov, E. Preobrazhenskaya, A. Iyevleva, 2016, Oncology Research and Treatment.

Gene rearrangements in consecutive series of pediatric inflammatory myofibroblastic tumors

E. Imyanitov, E. Preobrazhenskaya, A. Iyevleva, 2020, Pediatric blood & cancer.

First-Line Cetuximab Monotherapy in KRAS/NRAS/BRAF Mutation-Negative Colorectal Cancer Patients

A. Sokolenko, E. Imyanitov, E. Preobrazhenskaya, 2018, Clinical Drug Investigation.

The frequency and spectrum of PIK3CA mutations in patients with estrogen receptor-positive HER2-negative advanced breast cancer residing in various regions of Russia

E. Imyanitov, R. Zukov, A. Iyevleva, 2021 .

Lung carcinomas with EGFR exon 19 insertions are sensitive to gefitinib treatment.

E. Imyanitov, A. Iyevleva, N. Mitiushkina, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Down-Staging of EGFR Mutation-Positive Advanced Lung Carcinoma with Gefitinib Followed by Surgical Intervention: Follow-Up of Two Cases

E. Imyanitov, A. Iyevleva, V. Moiseyenko, 2009, Oncology Research and Treatment.

Myxopapillary Ependymoma of Lumbar Soft Tissue: A Case Report With Gene Expression Evaluation

A. M. Konstantinova, E. Imyanitov, A. Iyevleva, 2018, International journal of surgical pathology.

CCND1 and FGFR1 gene amplifications are associated with reduced benefit from aromatase inhibitors in metastatic breast cancer

E. Imyanitov, A. Iyevleva, S. Aleksakhina, 2020, Clinical and Translational Oncology.

MICROSATELLITE-UNSTABLE COLORECTAL CANCER IN ELDERLY PATIENTS: CLINICAL FEATURES AND THE ROLE OF IMMUNODEFICIENCY

E. Imyanitov, A. Iyevleva, G. Yanus, 2020, Siberian journal of oncology.

NBS1 657del5 mutation may contribute only to a limited fraction of breast cancer cases in Russia

P. Devilee, A. Sokolenko, E. Imyanitov, 2005, International journal of cancer.

Study of Selected BRCA1, BRCA2, and PIK3CA Mutations in Benign and Malignant Lesions of Anogenital Mammary–Like Glands

A. M. Konstantinova, E. Imyanitov, M. Michal, 2017, The American Journal of dermatopathology.

Integration of the blood test into the low-dose computed tomography lung cancer screening: reliable discrimination between malignant and non-malignant radiographic findings

E. Imyanitov, A. Iyevleva, E. Kuligina, 2021, Translational lung cancer research.

High response rates to neoadjuvant platinum-based therapy in ovarian cancer patients carrying germ-line BRCA mutation.

A. Sokolenko, E. Imyanitov, A. Iyevleva, 2015, Cancer letters.

Measurement of DPD and TS Transcripts Aimed to Predict Clinical Benefit from Fluoropyrimidines: Confirmation of the Trend in Russian Colorectal Cancer Series and Caution Regarding the Gene Referees

E. Imyanitov, A. Iyevleva, A. Togo, 2007, Oncology Research and Treatment.

Large family with both parents affected by distinct BRCA1 mutations: implications for genetic testing

A. Sokolenko, E. Imyanitov, V. Semiglazov, 2009, Hereditary cancer in clinical practice.

Hereditary Breast-Ovarian Cancer Syndrome in Russia

A. Sokolenko, E. Imyanitov, V. Semiglazov, 2010, Acta naturae.

High sensitivity of BRCA1-associated tumors to cisplatin monotherapy: report of two cases.

A. Sokolenko, E. Imyanitov, E. Kuligina, 2010, Cancer genetics and cytogenetics.

Identification of recurrent pathogenic alleles using exome sequencing data: Proof-of-concept study of Russian subjects.

A. Sokolenko, E. Imyanitov, A. Iyevleva, 2022, European journal of medical genetics.

Discrimination between Complete versus Non-Complete Pathologic Response to Neoadjuvant Therapy Using Ultrasensitive Mutation Analysis: A Proof-of-Concept Study in BRCA1-Driven Breast Cancer Patients

A. Sokolenko, E. Imyanitov, A. Iyevleva, 2023, International journal of molecular sciences.

Molecular testing and targeted therapy for non-small cell lung cancer: current status and perspectives.

E. Imyanitov, E. Levchenko, A. Iyevleva, 2020, Critical reviews in oncology/hematology.

Cytotoxic and targeted therapy for hereditary cancers

E. Imyanitov, A. Iyevleva, 2016, Hereditary cancer in clinical practice.

BRCA 1 4153 delA founder mutation in Russian ovarian cancer patients

A. Sokolenko, E. Imyanitov, A. Iyevleva, 2015 .

Evidence for predictive role of BRCA1 and bTUBIII in gastric cancer

E. Imyanitov, E. Kuligina, A. Iyevleva, 2013, Medical Oncology.

Founder mutations in early-onset, familial and bilateral breast cancer patients from Russia

P. Devilee, A. Sokolenko, E. Imyanitov, 2007, Familial Cancer.

BRCA1 4153delA founder mutation in Russian ovarian cancer patients

A. Sokolenko, E. Imyanitov, A. Iyevleva, 2006, Hereditary cancer in clinical practice.

Hereditary cancer syndromes

A. Sokolenko, E. Imyanitov, A. Iyevleva, 2023, World journal of clinical oncology.

Molecular tests for prediction of tumor sensitivity to cytotoxic drugs.

E. Imyanitov, A. Iyevleva, 2021, Cancer letters.

Molecular profiles of BRCA1‐associated ovarian cancer treated by platinum‐based therapy: Analysis of primary, residual and relapsed tumors

A. Sokolenko, E. Imyanitov, E. Preobrazhenskaya, 2020, International journal of cancer.

High prevalence and breast cancer predisposing role of the BLM c.1642 C>T (Q548X) mutation in Russia

A. Antoniou, A. Sokolenko, E. Imyanitov, 2012, International journal of cancer.

Pattern of clinically relevant mutations in consecutive series of Russian colorectal cancer patients

E. Imyanitov, E. Kuligina, A. Iyevleva, 2013, Medical Oncology.

MORPHOLOGIC AND MOLECULAR FEATURES OF PRIMARY GLIOBLASTOMA IN PATIENTS SURVIVING MORE THAN 3 YEARS

E. Imyanitov, V. Moiseenko, A. Iyevleva, 2019, Siberian journal of oncology.

Frequency and spectrum of founder and non-founder BRCA1 and BRCA2 mutations in a large series of Russian breast cancer and ovarian cancer patients

A. Sokolenko, E. Imyanitov, I. Berlev, 2020, Breast Cancer Research and Treatment.

Somatic loss of the remaining allele occurs approximately in half of CHEK2-driven breast cancers and is accompanied by a border-line increase of chromosomal instability

A. Sokolenko, E. Imyanitov, A. Iyevleva, 2022, Breast Cancer Research and Treatment.

High frequency of BRCA1 5382insC mutation in Russian breast cancer patients.

P. Devilee, A. Sokolenko, E. Imyanitov, 2006, European journal of cancer.

CHEK2 1100delC mutation is frequent among Russian breast cancer patients

P. Devilee, A. Sokolenko, E. Imyanitov, 2006, Breast Cancer Research and Treatment.

MEDICAL AND GENETIC COUNSELING OF HEREDITARY BREAST AND OVARIAN CANCER

A. Sokolenko, E. Imyanitov, A. Iyevleva, 2018, The Scientific Notes of the I. P. Pavlov St. Petersburg State Medical University.

Novel ALK fusion partners in lung cancer.

A. Sokolenko, E. Imyanitov, E. Kuligina, 2015, Cancer letters.

Candidate gene analysis of BRCA1/2 mutation-negative high-risk Russian breast cancer patients.

A. Sokolenko, E. Imyanitov, E. Preobrazhenskaya, 2015, Cancer letters.

EGFR T790M Mutation in TKI-Naïve Clinical Samples: Frequency, Tissue Mosaicism, Predictive Value and Awareness on Artifacts

A. Sokolenko, E. Imyanitov, E. Preobrazhenskaya, 2018, Oncology Research and Treatment.

Biased detection of guanine-rich microRNAs by array profiling: Systematic error or biological phenomenon?

Yoshio Miki, Natalia V. Mitiushkina, Aglaya G. Iyevleva, 2014, J. Comput. Sci..

High level of miR-21, miR-10b, and miR-31 expression in bilateral vs. unilateral breast carcinomas

Y. Miki, E. Imyanitov, E. Kuligina, 2012, Breast Cancer Research and Treatment.

EGFR mutation in kidney carcinoma confers sensitivity to gefitinib treatment: a case report.

E. Imyanitov, A. Iyevleva, V. Moiseyenko, 2009, Urologic oncology.

Evidence for angiogenesis-independent contribution of VEGFR1 (FLT1) in gastric cancer recurrence

A. Sokolenko, E. Imyanitov, V. Ehemann, 2013, Medical Oncology.

Exome-based search for recurrent disease-causing alleles in Russian population.

E. Imyanitov, M. Anisimova, A. Iyevleva, 2019, European journal of medical genetics.

CLINICAL EFFICACY OF TARGETED THERAPY TOWARDS METASTATIC LUNG CANCER CARRYING DISTINCT TYPES OF ALK REARRANGEMENTS

E. Filippova, A. Iyevleva, N. Mitiushkina, 2020, Siberian journal of oncology.

Variability in lung cancer response to ALK inhibitors cannot be explained by the diversity of ALK fusion variants.

I. S. Sardaryan, E. Imyanitov, E. Filippova, 2018, Biochimie.

Detection of EGFR mutations and EML4‐ALK rearrangements in lung adenocarcinomas using archived cytological slides

E. Imyanitov, A. Iyevleva, N. Mitiushkina, 2013, Cancer cytopathology.

BRAF-mutated clear cell sarcoma is sensitive to vemurafenib treatment

E. Imyanitov, A. Iyevleva, S. Aleksakhina, 2015, Investigational New Drugs.

High prevalence of GPRC5A germline mutations in BRCA1‐mutant breast cancer patients

A. Sokolenko, E. Imyanitov, J. Dixon, 2014, International journal of cancer.

Comprehensive evaluation of the test for 5′‐/3′‐end mRNA unbalanced expression as a screening tool for ALK and ROS1 fusions in lung cancer

E. Imyanitov, E. Preobrazhenskaya, E. Kuligina, 2022, Cancer medicine.

High Efficacy of First-Line Gefitinib in Non-Asian Patients with EGFR-Mutated Lung Adenocarcinoma

E. Imyanitov, A. Iyevleva, A. Togo, 2010, Oncology Research and Treatment.

KRAS, NRAS, BRAF, HER2 and MSI Status in a Large Consecutive Series of Colorectal Carcinomas

E. Imyanitov, A. Iyevleva, S. Aleksakhina, 2023, International journal of molecular sciences.

CYP17 and CYP19 genetic polymorphisms in endometrial cancer: association with intratumoral aromatase activity.

A. Sokolenko, E. Imyanitov, J. Thijssen, 2004, Cancer letters.

Unusual Clinical Presentation of Gastrointestinal Clear Cell Sarcoma

E. Imyanitov, A. Iyevleva, K. Pozharisski, 2015, Gastrointestinal Tumors.

High frequency of BRCA 1 , but not CHEK 2 or NBS 1 ( NBN ) , founder mutations in Russian ovarian cancer patients

A. Sokolenko, E. Imyanitov, A. Iyevleva, 2015 .

High frequency of BRCA1, but not CHEK2 or NBS1 (NBN), founder mutations in Russian ovarian cancer patients

A. Sokolenko, E. Imyanitov, A. Iyevleva, 2009, Hereditary cancer in clinical practice.

Distribution of EGFR Mutations in 10,607 Russian Patients with Lung Cancer

E. Imyanitov, M. Filipenko, I. Demidova, 2016, Molecular Diagnosis & Therapy.

Potential and real 'antineoplastic' and metabolic effect of metformin in diabetic and nondiabetic postmenopausal females.

E. Imyanitov, A. Iyevleva, L. Berstein, 2015, Future oncology.

Genetic polymorphisms potentially associated with response to metformin in postmenopausal diabetics suffering and not suffering with cancer

E. Imyanitov, A. Iyevleva, L. Berstein, 2013, Cell cycle.

ASSOCIATION OF CHEK 2 I 157 T POLYMORPHISM WITH THE RISK OF OVARIAN BORDERLINE CARCINOMAS IN RUSSIA

J. Lubiński, A. Sokolenko, E. Imyanitov, 2007 .

PALB2 mutations in German and Russian patients with bilateral breast cancer

T. Dörk, N. Bogdanova, M. Bremer, 2010, Breast Cancer Research and Treatment.

Endocrinology of obese and nonobese endometrial cancer patients: is there role of tumor molecular-biological type?

I. Berlev, A. Iyevleva, L. Berstein, 2019, Future oncology.

Spectrum of APC and MUTYH germ‐line mutations in Russian patients with colorectal malignancies

A. Sokolenko, E. Imyanitov, E. Preobrazhenskaya, 2018, Clinical genetics.

Vemurafenib-induced progression of breast cancer: a case report and review of the literature

E. Imyanitov, A. Iyevleva, G. Yanus, 2016, Targeted Oncology.

Efficacy of lorlatinib in lung carcinomas carrying distinct ALK translocation variants: The results of a single-center study

E. Imyanitov, E. Filippova, E. Preobrazhenskaya, 2021, Translational oncology.

KIT mutations in Russian patients with mucosal melanoma

E. Imyanitov, A. Iyevleva, A. Togo, 2011, Melanoma research.

Lack of Response to Imatinib in Melanoma Carrying Rare KIT Mutation p.T632I

E. Imyanitov, L. Demidov, A. Iyevleva, 2019, Case Reports in Oncology.

The spectrum of Lynch syndrome-associated germ-line mutations in Russia.

A. Sokolenko, E. Imyanitov, A. Iyevleva, 2020, European journal of medical genetics.

Rapid and Cost-Efficient Detection of RET Rearrangements in a Large Consecutive Series of Lung Carcinomas

E. Imyanitov, E. Preobrazhenskaya, A. Iyevleva, 2023, International journal of molecular sciences.

Real-world data on the incidence of immune-related adverse events associated with anti-PD-1/PD-L1 treatment in Russia

E. Imyanitov, A. Iyevleva, S. Protsenko, 2022, Problems in oncology.

Hereditary predisposition to kidney cancer: cancer syndromes, multisystemic disorders, and nephropathies

E. Imyanitov, A. Iyevleva, S. Aleksakhina, 2023, Sechenov Medical Journal.